Literature DB >> 2781907

[Lipid peroxidation processes in patients with schizophrenia].

E S Kovaleva, O N Orlov, M Ia Tsutsu'lkovskaia, T V Vladimirova, B S Beliaev.   

Abstract

In schizophrenic patients, the course of lipid peroxidation (LP) was investigated as indicated by pentane contents in the expired air (gas chromatography) during a course of psychotropic drug therapy. In 80% of the patients LP was activated before the therapy and reduced in its course with the levels in remission comparable to those characteristic of healthy controls. The LP decreased in a "leap-like" manner with episodes far exceeding the control levels. These leaps' rate and the baseline LP increase before therapy positively correlated with severity of the signs of the disease, its duration, and pre-existing level of negative disorders.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781907

Source DB:  PubMed          Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova        ISSN: 0044-4588


  5 in total

1.  Fatty acids and schizophrenia.

Authors:  J D Laugharne; J E Mellor; M Peet
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 2.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

Review 3.  Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

Authors:  J K Yao; R D Reddy; D P van Kammen
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Increased pentane and carbon disulfide in the breath of patients with schizophrenia.

Authors:  M Phillips; M Sabas; J Greenberg
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

5.  Volatile organic compounds in the breath of patients with schizophrenia.

Authors:  M Phillips; G A Erickson; M Sabas; J P Smith; J Greenberg
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.